Last updated: 16 June 2019 at 8:56am EST

John Tamerius Net Worth




The estimated Net Worth of John Tamerius is at least $4.74 millió dollars as of 25 November 2016. John Tamerius owns over 8,878 units of QuidelOrtho stock worth over $1,453,947 and over the last 16 years John sold QDEL stock worth over $3,288,544.

John Tamerius QDEL stock SEC Form 4 insiders trading

John has made over 20 trades of the QuidelOrtho stock since 2011, according to the Form 4 filled with the SEC. Most recently John exercised 8,878 units of QDEL stock worth $148,884 on 25 November 2016.

The largest trade John's ever made was selling 47,246 units of QuidelOrtho stock on 24 February 2014 worth over $1,308,242. On average, John trades about 5,395 units every 45 days since 2008. As of 25 November 2016 John still owns at least 32,418 units of QuidelOrtho stock.

You can see the complete history of John Tamerius stock trades at the bottom of the page.



What's John Tamerius's mailing address?

John's mailing address filed with the SEC is 101 MCKELLAR COURT, , SAN DIEGO, CA, 92121.

Insiders trading at QuidelOrtho

Over the last 21 years, insiders at QuidelOrtho have traded over $509,235,797 worth of QuidelOrtho stock and bought 304,015 units worth $10,385,234 . The most active insiders traders include Jack W Schuler, Matthew Strobeck és Group Inc.Carlyle Holdings .... On average, QuidelOrtho executives and independent directors trade stock every 16 days with the average trade being worth of $1,246,606. The most recent stock trade was executed by Group Inc.Carlyle Holdings ... on 9 August 2024, trading 74,134 units of QDEL stock currently worth $3,078,785.



What does QuidelOrtho do?

QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.



Complete history of John Tamerius stock trades at QuidelOrtho

Az érdekelt
Trans.
Tranzakció
Teljes ár
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $148,884
25 Nov 2016
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $78,550
26 Aug 2016
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $161,140
1 Aug 2016
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $161,140
1 Aug 2016
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $463,343
1 Dec 2015
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $134,530
20 Aug 2015
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $80,946
30 Jul 2015
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $42,500
3 Oct 2014
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $85,000
18 Sep 2014
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $367,500
23 Jul 2014
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $115,300
24 Jun 2014
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $1,308,242
24 Feb 2014
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $233,413
28 Feb 2013
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $582,400
21 Feb 2013
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $28,710
7 Dec 2012
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $72,920
4 Dec 2012
John Tamerius
Sr. VP - Clinical/Reg Affairs
Eladás $56,560
15 Mar 2012
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $32,063
21 Feb 2012
John Tamerius
Sr. VP - Clinical/Reg Affairs
Opció Gyakorlat $32,063
21 Feb 2012
John Tamerius
Sr. VP - Clinical/Reg Affairs
Megvenni $9,938
9 Aug 2011


QuidelOrtho executives and stock owners

QuidelOrtho executives and other stock owners filed with the SEC include: